Á lódáil...
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
BACKGROUND: Glioblastoma (GBM) is the most common and most malignant primary brain cancer in adults. Despite multimodality treatment, the prognosis is still poor. Therefore, further work is urgently required to discover novel therapeutic strategies for GBM treatment. METHODS: The synergistic effects...
Na minha lista:
| Foilsithe in: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167847/ https://ncbi.nlm.nih.gov/pubmed/30285808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0916-y |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|